New drug nezavist takes first step toward helping heavy drinkers

NCT ID NCT06633562

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Nezavist is safe for healthy adults and how the body processes it. Thirty-two volunteers will receive either the drug or a placebo. The results will guide future research on using Nezavist to help people drink less alcohol.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Altman Clinical and Translational Research Institute

    La Jolla, California, 92037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.